JBM (Healthcare) Limited (2161.HK)
HKD 1.97
(4.23%)
HKD 1.97
(4.23%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 130.46 Million HKD | 128.51% |
| 2022 | 57.09 Million HKD | 131.9% |
| 2021 | 24.62 Million HKD | 8.94% |
| 2020 | 22.6 Million HKD | -44.91% |
| 2019 | 41.02 Million HKD | -21.8% |
| 2018 | 52.45 Million HKD | 23.79% |
| 2017 | 42.37 Million HKD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | 62.46 Million HKD | 0.0% |
| 2023 FY | 130.46 Million HKD | 128.51% |
| 2023 Q4 | 68 Million HKD | 0.0% |
| 2022 FY | 57.09 Million HKD | 131.9% |
| 2022 Q4 | 35.53 Million HKD | 0.0% |
| 2022 Q2 | 21.56 Million HKD | 0.0% |
| 2021 Q2 | 10.04 Million HKD | 0.0% |
| 2021 FY | 24.62 Million HKD | 8.94% |
| 2021 Q4 | 14.58 Million HKD | 0.0% |
| 2020 Q2 | 21.65 Million HKD | 0.0% |
| 2020 Q4 | 950 Thousand HKD | 0.0% |
| 2020 FY | 22.6 Million HKD | -44.91% |
| 2019 FY | 41.02 Million HKD | -21.8% |
| 2018 FY | 52.45 Million HKD | 23.79% |
| 2017 FY | 42.37 Million HKD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -24.204% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 93.06% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 180.064% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 949.59% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 347.534% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -681.309% |
| Essex Bio-Technology Limited | 275.25 Million HKD | 52.604% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 552.321% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 222.984% |
| SSY Group Limited | 1.31 Billion HKD | 90.106% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | 51.132% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 96.615% |